Acetazolamide and Metabolic acidosis - a phase IV clinical study of FDA data

Summary:

Metabolic acidosis is found among people who take Acetazolamide, especially for people who are female, 30-39 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Acetazolamide and have Metabolic acidosis. It is created by eHealthMe based on reports of 4,756 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 20, 2022

4,756 people reported to have side effects when taking Acetazolamide.
Among them, 152 people (3.2%) have Metabolic acidosis.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 4,967 Acetazolamide users for its effectiveness, alternative drugs and more.

What is Metabolic acidosis?

Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body) is found to be associated with 2,057 drugs and 1,586 conditions by eHealthMe.

Number of Acetazolamide and Metabolic acidosis reports submitted per year:

Could Acetazolamide cause Metabolic acidosis?

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Metabolic acidosis?

Check whether Metabolic acidosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

Related studies

How severe was Metabolic acidosis and when was it recovered:

Metabolic acidosis in Acetazolamide

Expand to all the drugs that have ingredients of acetazolamide:

Metabolic acidosis and drugs with ingredients of acetazolamide (95 reports)

Alternative drugs to, pros and cons of Acetazolamide:

Acetazolamide (4,967 reports)

Common Acetazolamide side effects:

Drug ineffective: 433 reports
Headache (pain in head): 262 reports
Fatigue (feeling of tiredness): 246 reports
Breathing difficulty: 189 reports
Hypotension (abnormally low blood pressure): 177 reports
Diarrhea: 166 reports
Dizziness: 159 reports
Weakness: 157 reports

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Metabolic acidosis treatments and more:

Metabolic acidosis (29,365 reports)

COVID vaccines that are related to Metabolic acidosis:

Common drugs associated with Metabolic acidosis:

All the drugs that are associated with Metabolic acidosis:

Metabolic acidosis (2,057 drugs)

Common conditions associated with Metabolic acidosis:

Type 2 diabetes: 2,812 reports
High blood pressure: 2,572 reports
Diabetes: 1,832 reports
Pain: 951 reports
Depression: 647 reports

All the conditions that are associated with Metabolic acidosis:

Metabolic acidosis (1,586 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.